Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Anokion logo — Restoring normal IMMUNE TOLERANCE to treat autoimmune diseas...

Anokion

Restoring normal IMMUNE TOLERANCE to treat autoimmune disease

United States Cambridge, United States 31 employees

General Information

Company Name Anokion
Location United States Cambridge, United States +2
Employees 31
Social

Get notified when Anokion moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Anokion

Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.

No funding data available for Anokion yet.

Get notified when Anokion raises funding

Anokion Alternatives & Competitors

Anokion vs
Delinia
Delinia United States

Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus on enhancin...

Acquired
3 employees
Biotechnology, Health and Wellness
Anokion vs
Immune Tolerance Network
Immune Tolerance Network

The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the N...

36 employees
Anokion vs
COUR Pharma
COUR Pharma United States

Reprogramming the immune system to restore health in people suffering from autoimmune diseases

Series A
61 employees
Biotechnology, Health and Wellness

FAQ About Anokion

Restoring normal IMMUNE TOLERANCE to treat autoimmune disease
Anokion is headquartered in Cambridge, United States.
Anokion has approximately 31 employees.
Top alternatives and competitors to Anokion include Delinia, Immune Tolerance Network, COUR Pharma, AbolerIS Pharma, Topas Therapeutics GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anokion and Delinia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Anokion and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy